Siglec-8 is a human immune-inhibitory receptor that, when engaged by specific self-glycans, triggers eosinophil apoptosis and inhibits mast cell degranulation, providing an endogenous mechanism to down-regulate immune responses of these central inflammatory effector cells. Here we used solution NMR spectroscopy to dissect the fine specificity of Siglec-8 toward different sialylated and sulfated carbohydrate ligands and determined the structure of the Siglec-8 lectin domain in complex with its prime glycan target 6′-sulfo sialyl Lewis x . A canonical motif for sialic acid recognition, extended by a secondary motif formed by unique loop regions, recognizing 6-O-sulfated galactose dictates tight specificity distinct from other Siglec family members and any other endogenous glycan recognition receptors. Structure-guided mutagenesis revealed key contacts of both interfaces to be equally essential for binding. Our work provides critical structural and mechanistic insights into how Siglec-8 selectively recognizes its glycan target, rationalizes the functional impact of site-specific glycan sulfation in modulating this lectin-glycan interaction, and will enable the rational design of Siglec-8-targeted agonists to treat eosinophil-and mast cell-related allergic and inflammatory diseases, such as asthma.
D
iscrimination between self and nonself constitutes one of the most challenging tasks for the immune system. Innate immunity relies on an array of germ-line-encoded receptors that detect conserved features on invaders, providing immediate defense against infection, whereas adaptive immunity ensures to keep pace with the vast diversity of constantly evolving pathogenic threats. To prevent self-destructive immune responses, both systems are counterbalanced by inhibitory receptors that down-regulate immune activation upon sensing molecular markers of self. Glycans decorating the surfaces of all living cells are at the forefront of such recognition processes, providing with their unique and complex structures highly discriminative signatures of cellular identity. Terminal sialic acids are an immunological hallmark of vertebrate self-glycans (1) (2) (3) , and recent evidence suggests glycan sulfation to be another self-marker specific to mammals (4) .
Sialic acid-binding Ig-like lectins (Siglecs) represent the largest family of mammalian innate-immune cell surface receptors that recognize self-associated glycans and convert these extracellular recognition events into inhibition of immune cell function (2, 3, 5) . To date, 14 human Siglecs have been identified, mostly expressed on various leukocyte populations. Each Siglec displays extracellularly a unique N-terminal lectin domain that binds distinct sialic acid-containing glycan (sialoglycan) ligands, and most members contain conserved immunoreceptor tyrosine-based inhibitory motifs (ITIMs) (6) in their cytoplasmic tails. Ligand-induced activation results in ITIM-phosphorylation by Src family tyrosine kinases and recruitment of SH2-containing phosphatases (SHPs), which interfere with activation pathways of the underlying cell (2) . Although Siglecs are generally known to control and balance immune cellular responses by acting as inhibitory receptors, recent studies intriguingly demonstrated that signaling of specific members is implicated in the regulation of the life span of immune cells, expanding their function as immune modulators to potential mediators of immune homeostasis (7) .
Most prominently, Siglec-8, originally identified from a cDNA library derived from a patient suffering from hypereosinophilic syndrome (8, 9) , has emerged as a critical negative regulator of inflammatory response during allergic airway inflammation. It is highly and exclusively expressed on human eosinophils and mast cells and weakly on basophils and is conserved only among primates, but it lacks clear orthologs in any other mammalian species. Cross-linking of Siglec-8 on eosinophils with antibodies or a synthetic glycan ligand-coated polymer in vitro induces their rapid apoptosis (10, 11) , whereas on mast cells, Siglec-8 ligation results in the inhibition of IgE/FceRI-mediated inflammatory mediator release, without affecting their survival (12) . Preactivation of eosinophils with survival-promoting, proinflammatory cytokines, a key process in allergic inflammation, not only fails to counteract Siglec-8-triggered cell death but instead potently enhances their sensitivity to undergoing apoptosis in response to Siglec-8 ligation
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This article is a PNAS Direct Submission. (13-15), suggesting a particular role for Siglec-8-mediated immune suppression under inflammatory conditions. Supporting this notion, an ex vivo study showed that eosinophils isolated from the brochoalveolar fluid of allergen-challenged patients have increased susceptibility to Siglec-8-mediated apoptosis (16) . Immunohistochemical analysis consistently revealed that endogenous Siglec-8 ligands are markedly up-regulated in inflamed compared with normal human airway tissues (17) . Collectively, these findings led to the proposal that Siglec-8 may provide a safeguard mechanism for the immune system to selectively deplete eosinophils from inflamed tissues and simultaneously diminish mast cell inflammatory responses and may thus constitute a basic immunoregulatory pathway to trigger the active resolution of inflammation and return to homeostasis (7, 18) (Fig. 1A) . There is increasing awareness that dysregulated Siglec-8 function might be critically involved in the pathobiology of allergic and chronic inflammatory disorders, including asthma, where accumulation and delayed apoptosis of activated eosinophils and mast cells in the airways are among the leading causes of persistent inflammation and tissue damage (19, 20) . Indeed, Siglec-8 gene polymorphisms were identified to correlate with increased asthma risk (21) , albeit the detailed molecular pathways linking Siglec-8 to disease have yet to be clarified. On account of its potent eosinophil proapoptotic and mast cell-inhibitory activities, combined with its selective expression on these key inflammatory effector cells, Siglec-8 is considered a promising target for novel antiinflammatory, proresolving treatment strategies for asthma and other disease conditions in which inappropriate and/or prolonged inflammatory responses of these cell types contributes to pathology (20, (22) (23) (24) (25) .
Understanding the structural basis of how Siglec-8 interacts with its carbohydrate ligand is an essential prerequisite for deciphering its molecular mechanism of action, under both physiological and pathological conditions, and will facilitate the rational design of highly specific agents to exploit its antiinflammatory signaling pathway for therapeutic purposes. Although the exact biochemical identity of its natural tissue ligands still remains unknown, glycan microarray analyses have revealed tight specificity for a unique sulfated and sialylated tetrasaccharide glycan epitope, termed 6′-sulfo sialyl Lewis x (6′S sLe x ) or Neu5Acα2- (26, 27) , whereas no binding was detected to the closely related 6S sLe x (Neu5Acα2-3Galβ1-4[Fucα1-3][6S]GlcNAc) or the nonsulfated sLe x , which are known ligands for E-, P-, and L-selectins (28) .
Here we present the solution structures of the human Siglec-8 lectin domain in its ligand-free form and in complex with its preferred glycan epitope 6′S sLe x . Our structural analysis, combined with quantitative binding studies and site-directed mutagenesis data, provides detailed insight into how Siglec-8 selectively recognizes its glycan target and demonstrates the critical influence that site-specific glycan sulfation can exert in the modulation of lectin-glycan recognition.
Results
Fine Specificity Toward Differently Sulfated sLe x Glycan Epitopes
Assessed by Solution NMR. Previous glycan microarray analyses concordantly identified 6′S sLe x as the best candidate ligand for Siglec-8 (26, 27) , whereas a subsequent study indicated strongest binding to the disulfated 6,6′S sLe x (29) , which contains an additional sulfate group at the C6 position of the GlcNAc moiety. N-HSQC spectrum each NH group is represented by a cross-peak whose spectral position directly reflects its individual local chemical environment. Ligand-binding leads either to gradual changes in cross-peak positions (fast exchange) or to the appearance of new cross-peaks (slow exchange), as ligand concentration is increased. This experimental strategy allowed not only detection and mapping of carbohydrate binding directly on the protein at residue-specific precision but also quantification of monovalent interactions under nearly physiological solution conditions, which is feasible even for weak-affinity interactions (K d in the μM to mM range). Binding of each of the four tetrasaccharides induced substantial chemical shift changes in a number of Siglec-8 amide resonances and was characterized by fast exchange kinetics on the NMR time scale (Fig. S1 ). Perturbed residues clustered to the same discrete sequence regions of Siglec-8, indicating that each of the four sLe x variants occupies the same binding surface, whereas the magnitudes of the chemical shift changes differed markedly between the four titrations ( Fig. 2B and Fig. S1 ). Examination of the overlaid N-HSQC titration spectra revealed that most of the perturbed cross-peaks followed similar trajectories, consistent with a similar ligand orientation. However, dependent on the presence or absence of the sulfate at the C6 position of the Gal, the crosspeaks of Tyr58 and Gln59 moved into different directions (Fig.  S1B ), suggesting their proximity to the sulfate recognition site.
NMR titration curves of significantly perturbed and wellresolved resonances were used to extract equilibrium dissociation constants (K d ) ( Fig. 2C and Fig. S2 ), revealing a distinct hierarchy of binding strengths: sLe x binds with the weakest affinity (K d : 8.3 ± 1.9 mM), and the additional presence of a sulfate group at the C6 position of the GlcNAc moiety of 6S sLe x resulted in only a modest gain in affinity (K d : 2.7 ± 0.8 mM; threefold compared with sLe x ). In contrast, the presence of a single sulfate group at the C6 position of the Gal moiety of 6′S sLe x -the presumed Siglec-8 ligand (26, 27)-produced a dramatic increase in affinity (K d : 295 ± 26 μM; 28-fold compared with sLe x ). A similar, however, slightly higher, affinity was determined for the disulfated 6,6′S sLe x (K d : 185 ± 18 μM; 1.6-fold compared with 6′S sLe x ). To quantify further Siglec-8 binding to 6′S sLe x and to elucidate the thermodynamics of this interaction, we used isothermal titration calorimetry (ITC) (Fig. 2D ) and a competitive binding ). Based on these observations, we concluded that 6′S sLe x contains the minimum epitope specifically recognized by Siglec-8.
Structure of the Human Siglec-8 Lectin Domain. To gain insights into the structural determinants underlying this narrow target specificity, we determined the 3D structure of the human Siglec-8 lectin domain by solution NMR spectroscopy ( Table S1 ). The structure revealed a canonical Siglec lectin domain fold, which is a V-set Ig-like β-sandwich of two antiparallel β-sheets formed by β-strands ABED and C′CFG. Characteristic features of Siglec lectin domains were observed: the conserved intrasheet disulfide bond between adjacent β-strands B and E; the strictly conserved essential arginine (Arg109) on β-strand F, known to provide a key salt bridge interaction for sialic acid recognition; and the splitting of the G-strand into two shorter β-strands (G and G′). Structural alignment with available crystal structures of Siglec-1 (32), Siglec-5 (33), and Siglec-7 (34) revealed, besides a nearly invariant core, large conformational differences in the N-terminal segments (before β-strand A) and the B′C intersheet loops, as well as the CC′ and GG′ interstrand loops (Fig. 3D ). These four regions show the highest sequence diversity between the lectin domains of the different human Siglec family members, while being highly conserved among primate Siglec-8 orthologs (sequence alignment shown in Fig. S3A ). Remarkably, the GG′ loop of Siglec-8, consisting of 11 residues, is substantially extended compared with the typically 5 residue-spanning GG′ loops of most Siglecs. Notably, in Siglec-7 and Siglec-9, the CC′ and GG′ loops had been found to contribute interactions to glycan moieties underlying a terminal sialic acid (35, 36) and are thus the presumed key determinants for the distinct fine carbohydrate specificities of individual Siglecs. Consistently, both loops displayed large chemical shift perturbations upon ligand binding (Fig. 2B) . Backbone { 1 H}-15 N-heteronuclear nuclear Overhauser effect (hetNOE) measurements (Fig. 3E ) indicated that both loops are well ordered and do not exhibit conformational dynamics on the here probed picosecond-to-nanosecond time scale, which may in part originate from a stabilizing network of hydrogen bonds and salt bridges (Fig. S3 C-F) . To understand the structural basis for glycan recognition and discrimination by Siglec-8, we next determined the solution structure of the human Siglec-8 lectin domain in complex with 6′S sLe x by NMR spectroscopy. Despite the weak binding affinity (K d in the high micromolar range), 113 intermolecular NOEs-a large number for a tetrasaccharide ligand-could be unambiguously identified and converted into distance restraints ( Fig. S4 A and B) . Based on these, plus 104 intracarbohydrate and 3,938 intraprotein NOE-derived distance restraints, we determined a precise structural ensemble of the complex (Fig. 3F and Table S1 ). Overall, the structure of Siglec-8 in the complex is virtually identical to that of the unliganded Siglec-8 (Cα rms deviation of 0.8 ± 0.1 Å for residues 7-135), indicating that carbohydrate recognition is mediated by a largely preformed binding site, involving only minor side chain rearrangements. The carbohydrate lies embedded in a highly positively charged cleft formed by β-strands C, F, and G encompassed by the Siglec-8-unique CC′ and GG′ loops (Fig. 3 G-I ). About 678 Å 2 or 46% of its solventaccessible surface is buried upon binding to Siglec-8. The entire tetrasaccharide is well-ordered, showing a single major conformation throughout the ensemble with tightly clustered glycosidic torsion angles for the core Le x trisaccharide: for the Galβ1-4GlcNAc linkage, 47°< φ < 54°and 12°< ψ < 19°; for Fucα1-3GlcNAc linkage, 47°< φ < 51°and 16°< ψ < 20°, and there was a slightly wider spread of angles for the terminal Neu5Acα2-3Gal linkage, −94°< φ < −66°and 18°< ψ < 25°(see Materials and Methods for angle definitions).
Intermolecular Contacts at the Complex Interface. Closer inspection of the binding interface (Fig. 4) revealed that specificity is achieved by two major hot spots: a primary motif for recognition of the terminal Neu5Ac, extended by a secondary motif recognizing the subterminal galactose-6-sulfate (Gal6S). A summary of observed intermolecular contacts in the Siglec-8-6′S sLe x complex is given in Table 1 . The Neu5Ac is located at the edge of the G-strand, such that its carboxyl group makes a salt bridge with the guanidinium group of the strictly conserved essential Arg109 (on the adjacent F-strand), whose orientation itself is stabilized by salt bridge/hydrogen bond interactions with the side chains of Glu111 (F-strand) and Ser118 (G-strand). The Neu5Ac pyranose ring packs tightly with its hydrophobic A-face (Materials and Methods) against the aliphatic portion of Lys116, which protrudes from the upper part of the G-strand, likely providing an upper boundary for the Neu5Ac recognition site. The N-acetyl amide and the O8 and O9 hydroxyl groups of the glycerol chain form a network of hydrogen bonds with backbone atoms of the G-strand residues Lys116 and Ser118. In addition, the N-acetyl methyl group, together with the H7 and the H91/H92-methylene atoms, makes intimate hydrophobic contacts with the surrounding aromatic rings of Tyr11 and Trp117 (Fig. 4 A-C) . Notably, the interactions engaging Neu5Ac and its orientation on the Siglec-8 surface are nearly identical to those seen in structures of other Siglec family members (32, 33, 36) , as was expected from sequence comparisons. However, an additional hydrogen bond is formed between the O7 hydroxyl group of Neu5Ac and the side chain hydroxyl group of Tyr7 located in the unique N-terminal extension of Siglec-8 (Fig. 4 A-C and Fig. S3A) .
The most striking and distinguishing feature of this complex is the recognition of the Gal6S, which is mediated exclusively by the side chains of three residues (Arg56, Tyr58, and Gln59) on the Siglec-8-unique CC′ loop (Fig. 4 D and E) . The aromatic ring of Tyr58 lies flat and exposed on top of the CC′ loop, providing a platform for CH/π-stacking interactions with the apolar B-face of the galactopyranose ring, particularly with the plane formed by H3, H4, and H5. The exocyclic moiety of Gal6S approaches the edge of the CC′ loop and positions the negatively charged sulfate group in the center of the flanking Arg56 and Gln59 side chains, thereby forming a salt bridge with the guanidinium group of Arg56 and/or a hydrogen bond with the NH 2 of Gln59. Remarkably, in 9 of the 20 refined structures, both side chains embrace the sulfate from opposite sides in a clamp-like configuration, thus contributing simultaneously to its recognition. These interactions are confirmed by the chemical shift changes of the Arg56 and Gln59 side chain amides observed only upon titration with sLe x variants containing a Gal-6-sulfate modification (Figs. S1B and S4D ).
Only few intermolecular contacts were found with the GlcNAc: its apolar B-face and N-acetyl group are exposed to solvent, whereas its exocyclic hydroxymethylene group (directed toward the Neu5Ac glycerol chain) is interacting with the long and flexible side chains of Lys120 and Gln122 on the GG′ loop. In most structures of the ensemble, the GlcNAc O6 is hydrogen bonded by the positively charged NH 3 + of Lys120 (Fig. 4F) , which otherwise donates a hydrogen bond to the nearby Neu5Ac O9. In few structures, the GlcNAc O6 is hydrogen bonded by the NH 2 of Gln122, which in turn forms in some structures a hydrogen bond with the O9 of Neu5Ac (Fig. 4 B and C and Table 1 ).
The 3-amino-propyl linker, attached to the reducing end of the tetrasaccharide, exits the binding site toward the tip of the GG′ loop (close to Gln122 and Leu123; Fig. 4F ) and appears disordered. No intermolecular contacts were found to Fuc. Its B-face is fully solvent-exposed, whereas its A-face stacks onto the A-face of the Gal6S, stabilizing the Le x conformation by donating an intracarbohydrate C-H···O hydrogen bond from its C5-H5 to the O5 ring oxygen of the Gal6S (Fig. 4F) , as has been found previously in structures of Le x (37) and sLe x (38) oligosaccharides. The presence of this hydrogen bond is indicated by the distance between Fuc-H5 and Gal-O5 of 2.2-2.3 Å within the ensemble, which is significantly shorter than the sum of the corresponding van der Waals radii (2.6 Å), and further supported by the characteristic NMR chemical shift of Fuc-H5 (∼4.8 ppm) (37, 38) .
Mutations of Key Interface Residues Impair Siglec-8 Binding to 6′S sLe
x . To dissect quantitatively the contributions of individual amino acid side chains to carbohydrate recognition, we introduced several single alanine substitutions at the interface and measured Note that all intermolecular restraints used for structure calculation were derived from intermolecular NOE data, and none of the listed interactions was used as artificial input. their effects on binding to 6′S sLe x by using NMR titration experiments ( Fig. 5 A and B and Fig. S5 ). None of these mutations affected the overall structure of Siglec-8, as indicated by very similar 2D 1 H, 15 N-HSQC fingerprint spectra compared with the wild-type protein. As expected, substitution of the strictly conserved essential Arg109, which eliminated the salt bridge with the Neu5Ac carboxyl group, completely abrogated binding, confirming its indispensable role in carbohydrate recognition. Substitution of Lys116, which participates in hydrophobic contacts with the Neu5Ac pyranose ring, strongly impaired binding (sevenfold loss in affinity). A similar drastic drop in affinity (eightfold) resulted from substitution of Arg56 on the CC′ loop, whereas substitutions of the adjacent Tyr58 or Gln59 only modestly affected binding (twofold affinity decrease for each mutant). Hence, a major contribution to the binding energy must originate from the salt bridge formation between the Arg56 guanidinium group and the sulfate. Substitution of the GG′ loop residue Lys120, which forms hydrogen bonds with the GlcNAc O6 and/or the Neu5Ac O9, had a large effect on binding (eightfold drop in affinity). In contrast, substitutions of its neighboring GG′ loop residues Gln122 or Leu123 had only minor effects on binding (less than twofold affinity decrease for each mutant).
Overall, substitutions of the positively charged residues at the binding site (Arg56, Arg109, Lys116, and Lys120) caused the largest reductions in binding affinity. Besides providing specific hydrogen-bonding contacts, these tightly clustered positive charges (Fig. 3 H and I ) may contribute to a substantially enhanced association rate (k on ) owing to attractive Coulomb interactions (40) with the doubly negatively charged carbohydrate ligand. Electrostatic enhancement of complex formation has been described for protein-RNA interactions, where binding can be several orders of magnitude faster than in a purely diffusionlimited process (41) , and is particularly conceivable for the present interaction characterized by fast-exchanging free and bound states. It is plausible that this effect is further amplified when clustered receptors on cell surfaces avidly interact with multivalently presented glycan epitopes on large polysaccharide or mucin-type glycoprotein ligands, leading to markedly higher in vivo binding affinities, compared with the here investigated monovalent lectin-glycan interaction.
Discussion
Here we have elucidated the molecular basis of how human Siglec-8 selectively recognizes its principal carbohydrate target 6′S sLe
x . Our comparative analysis, combined with previous functional studies (26, 27) , provides clear evidence that Siglec-8 preferentially recognizes sLe x epitopes, which display a sulfate group at the C6 of the Gal moiety, and demonstrates that both the presence and position of this modification are critical determinants of Siglec-8 specificity. Quantification revealed the sulfate group to account for a 28-fold greater affinity for binding to 6′S sLe x (K d ' 300 μM), compared with nonsulfated sLe
In contrast, a sulfate modification at the C6 of the GlcNAc moiety was found to make only a minor contribution to binding affinity ( Fig. 2 B and C) . The solution structure of the Siglec-8 lectin domain in complex with 6′S sLe x explains these differences in affinity, revealing that tight specificity results from the unique combination of a primary recognition motif for terminal Neu5Ac, which is largely canonical among Siglecs, and a secondary motif for recognition of the underlying Gal6S, which is exclusive to Siglec-8. Conservation analysis of the Siglec-8 binding interface across the human Siglec family (Fig. 5C) shows that only residues engaging Neu5Ac have elevated levels of conservation, whereas all interactions to the underlying glycan moieties are solely mediated through nonconserved side chains. High selectivity for Gal6S is conferred by the cooperative action of three residues on the Siglec-8-unique CC′ loop (Arg56, Tyr58, and Gln59), and mutational dissection revealed this interaction to be dominated by a salt bridge between the Arg56 guanidinium and the sulfate group of Gal6S (Figs. 4 D and E and 5) . Although GlcNAc makes direct protein contacts that contribute to affinity, the low number and high variability of interactions observed in the NMR ensemble (Table 1) imply only a minor role for this residue in specificity. Notably, the O6 of GlcNAc is anchored in the interior of the binding groove by hydrogen bonds with the side chains of Lys120 and/or Gln122 (Fig. 4F and Table 1 ), thus suggesting how the GlcNAc-6-sulfate group in 6S sLe x and 6,6′S sLe x ligands may be contacted by Siglec-8. However, molecular modeling of the Siglec-8-6,6′S sLe x complex (Fig. S6) indicates that binding of a bulkier sulfate would interfere with the architecture of the binding pocket, implying that the small net gain in affinity produced by a GlcNAc-6-sulfate modification may arise from additional favorable electrostatic and hydrogen bonding interactions, largely counteracted by less favorable steric complementarity. The lack of contacts to Fuc, which projects away from the Siglec-8 surface, is consistent with a recent glycan microarray analysis (42) where a Siglec-8-IgFc fusion protein was found to bind to 6′S sLacNAc (6′-sulfo 3′-sialyl N-acetyllactosamine; corresponding to 6′S sLe x , minus α1,3-linked Fuc), in addition to 6′S sLe x , suggesting this monosaccharide to be dispensable for Siglec-8 recognition. However, Fuc stabilizes the core Le x trisaccharide in a binding-competent conformation by forming an intracarbohydrate C-H···O hydrogen bond to Gal6S (Fig. 4F) , together with hydrophobic interactions (37, 38, 43) , and may thus indirectly contribute to affinity by decreasing the entropic penalty of fixing multiple conformational degrees of freedom upon binding.
Disruption of the salt bridge to the Neu5Ac carboxylate by mutation of the essential Arg109 leads to a complete loss of binding, and similarly, without Gal-6-sulfation the binding affinity is decreased to values that are likely well below the threshold needed for Siglec-8 signaling activation. Together this demonstrates that simultaneous recognition of Neu5Ac and the underlying Gal6S is absolutely required for effective Siglec-8 engagement. Considering that no other human Siglec, nor any other known endogenous receptor, shares this carbohydrate specificity, this unique binding mode may ensure a maximum control of the Siglec-8 antiinflammatory signaling pathway, while safeguarding against cross-activation by other sialylated glycans omnipresent on vertebrate cell surfaces or by hijacking pathogens decorated with sialic acids to evade host immune surveillance.
Of note, murine Siglec-F has been considered, albeit controversially, to be a functional paralog of Siglec-8, owing to a similar (although less restricted) expression pattern, glycan specificity, and ligation-induced proapoptotic effects, and was therefore proposed as an in vivo model for exploring Siglec-8 function in mice (3, 27) . In light of our results, sequence analysis reveals that key residues of Siglec-8 responsible for the sulfate recognition are maintained only across its primate orthologs but are absent in Siglec-F (Fig. S3A) , suggesting either that Siglec-F recognizes 6′S sLe
x by a distinct mode or, in support of recent findings (44, 45) , that Gal C6 sulfation is not required for Siglec-F ligands.
Our findings also established that a single sulfate modification at the Gal C6 renders the poor-affinity sLe x glycan epitope into the preferred ligand for Siglec-8 and thus into a potential antiinflammatory signal. By contrast, nonsulfated sLe x and variants carrying a sulfate group at GlcNAc C6 are known ligands for the selectin family of cell adhesion receptors (E-, P-, and L-selectin) (28) that mediate the recruitment of leukocytes (including eosinophils and mast cells) to inflammatory sites. Given that selectins play key roles in the initiation of eosinophil inflammation, whereas Siglec-8 appears to be implicated in resolving eosinophil inflammatory responses, it is tempting to speculate that site-specific sulfation of the sLe x epitope acts as one of the molecular switches that dictate whether eosinophil inflammation is initiated or terminated.
Our results provide unprecedented atomic-level insight on how site-specific glycan sulfation can potently modulate glycan affinity and specificity to prime its selective recognition by its cognate receptor. This type of glycan modification adds, in addition to the nonlinearity and multitude of linkage sites per monosaccharide, yet another layer of complexity to the coding capacity of glycan structures and hence to the processes controlled by their recognition. Future studies identifying and characterizing the involved glycan-editing sulfotransferases and sulfatases will be crucial to understand further the intricate role of glycan sulfation in immune regulation and inflammation, as well as for developing new strategies for therapeutic intervention.
Collectively, we report here the complete molecular and structural description of how a Siglec receptor specifically recognizes its entire glycan ligand epitope, revealing the key determinants of glycan specificity and discrimination. Whereas the conserved sialic acid recognition motif governs general specificity, local sequence diversity in the variable loop regions defines the fine specificity and translates into unique binding modes, enabling individual Siglec family members to participate in distinct and discrete immune-regulatory functions. This work will help elucidate the precise role and mechanism of Siglec-8 in immune cell homeostasis and inflammation resolution and provides a structural template for the rational design of Siglec-8 agonists to harness its potent signaling capacity in novel antiinflammatory therapies for asthma.
Materials and Methods
Carbohydrates. The 6-sulfo sialyl Lewis x , 6′-sulfo sialyl Lewis x , and 6,6′-disulfo sialyl Lewis x were chemically synthesized as described in SI Appendix. Methyl sialyl Lewis x was purchased from Carbosynth. Identity and purity of all carbohydrates was assessed by 2D NMR spectroscopy.
Protein Expression and Purification. Proteins were expressed recombinantly and purified as described elsewhere (30) . In brief, human Siglec-8 lectin domain (Met1-His139, containing a C26S point mutation to facilitate soluble expression; herein referred to as wild type), C-terminally fused to a thrombin cleavage-site and a His 6 -tag, was natively expressed in the oxidative cytoplasm of Escherichia coli Rosetta-gami B (trxB − /gor − ) (Novagen), using LB Structure Calculation and Refinement. The software package ATNOS CANDID (49, 50) was used for picking of initial cross-peaks of NOESY spectra. The resulting peak lists were assigned using a combination of manual and automated assignments within the NOEASSIGN module of CYANA 3.0 (51). For the complex, an extended CYANA library including the carbohydrate residues was used, for which the topology was derived from a structural model of sLe x that was generated in SWEET2 (www.glycosciences.de) (52) and modified for addition of the 3-aminopropyl-aglycon at C1 of GlcNAc and the sulfate group at C6 of Gal within ChemBio 3D Ultra 12.0 (Cambridge Soft). Structure calculations with torsion-angle dynamics were conducted within CYANA 3.0 (51), using additional restraints for backbone torsion angles derived from chemical shifts by using the program TALOS+ (53), stereospecific assignments of Val and Leu prochiral methyl groups, restraints for the disulfide bond generated with the CYANA macro ssbond, and distance restraints for intraprotein hydrogen bonds, based on the observation of slow-exchanging amide hydrogens in D 2 O. Hydrogen bond acceptors were identified from inspection of initial structures. Two hydrogen bonds involving Tyr hydroxyl groups (Tyr106 and Tyr119) were identified from detection of their H η resonances in an F 2 -filtered NOESY measured in H 2 O and also in 15 N-and 13 C-edited 3D NOESY spectra, indicating protection from proton exchange, which typically prevents the observation of such signals. Intracarbohydrate and intermolecular (protein-carbohydrate) NOEs were assigned manually and converted into distance restraints based on cross-peak signal-to-noise (S/N) ratios. From 500 structures calculated in CYANA 3.0 (51) the 50 lowest-energy conformers were refined within AMBER 12 (54) , using the ff12SB force field for the protein and simultaneously the GLYCAM_06h force field (55) for the protein-carbohydrate complex, in implicit solvent. For the 3-aminopropyl-linker the topology and parameters files were computed within Antechamber (56), using the General Amber Force Field (57) and the AM1-BCC (58) model for assignment of partial atomic charges. The 20 best structures were selected and analyzed with PROCHECK-NMR (59). The Ramachandran statistics for Siglec-8 (residues 7-136) are 89.7% in most favored and 10.3% in additionally favored regions for the free protein and 90.4% in most favored and 9.6% in additionally favored regions for the protein in the complex. The NMR and refinement statistics are provided in Table S1 . Carbohydrate conformations in the NMR ensemble of the complex were compared by glycosidic torsion angles (φ, ψ), defined as φ = H1-C1-OX-CX and ψ = C1-OX-CX-HX, where X is the number of the carbon atom of the second monosaccharide involved in the glycosidic linkage. For the Neu5Ac(α2-3)Gal linkage, angles are defined as φ = C1-C2-OX-CX and ψ = C2-OX-CX-HX. A-face and B-face of the described monosaccharides are defined as the faces on which the numbering of the carbon atoms increases in a clockwise and anticlockwise direction, respectively. Structural figures were prepared using PyMOL (Schrödinger, LLC). Isothermal Titration Calorimetry. ITC was performed using a VP-ITC microcalorimeter (MicroCal). Prior the experiment the carbohydrate was dialyzed against 20 mM potassium phosphate, 40 mM NaCl, pH 7.4 (same buffer as used for the protein), using a Micro DispoDIALYZER (100 Da MWCO; Harvard Apparatus). The microsyringe was loaded with a solution of carbohydrate (7 mM), and the sample cell was loaded with a solution of protein (200 μM). Titration was conducted at 20°C using one initial injection of 2 μL with a duration of 4 s and 400 s spacing, followed by 34 identical injections of 4 μL with a duration of 8 s per injection and 10 min spacing between injections. Data were analyzed using the MicroCal ITC module of Origin 7.0 (OriginLab), applying a single-site binding model.
NMR
Competitive Binding Assay. Polyacrylamide-based competitive binding assay (31) was used to evaluate the binding affinity of Siglec-8 for 6′S sLe x . Microtiter plates (F96 MaxiSorp, Nunc) were coated with 100 μL per well of a 10 μg/mL solution of Siglec-8 lectin domain in assay buffer (20 mM Hepes, pH 7.4; 150 mM NaCl; and 1 mM CaCl 2 ), overnight at 4°C. The coating solution was discarded, and the wells were blocked with 150 μL per well of 3% BSA in assay buffer for 2 h at 4°C. After three washing steps with assay buffer (150 μL per well), a threefold serial dilution of the 6′S sLe x ligand (50 μL per well) in assay buffer and streptavidin-peroxidase coupled polyacrylamide glycopolymer [6′S sLe
x -PAA (Lectinity), 50 μL per well of a 0.3 μg/mL solution] were added. The plate was incubated on a thermoshaker (PHMP-4, Grant Instruments) for 3 h at 25°C and shaking speed 350 rpm and then carefully washed four times with 150 μL per well assay buffer. After the addition of 100 μL per well of the horseradish peroxidase substrate 2,2′-azino-di(3-ethylbenzthiazoline-6-sulfonic acid), the colorimetric reaction was allowed to develop for 3 min, then stopped by the addition of 2% aqueous oxalic acid, before the optical density was measured at 415 nm on a microplatereader (Spectramax 190, Molecular Devices). The IC 50 value of 6′S sLe x was calculated with the Prism software (GraphPad Software, Inc.). The IC 50 defines the molar concentration of the test compound that reduces the maximal specific binding of 6′S sLe x -PAA polymer to Siglec-8 by 50%.
Modeling of Human Siglec-8-6,6′S sLe x Complex. A structural model of the Siglec-8-6,6′S sLe x interaction was generated by using the Siglec-8-6′S sLe x complex NMR structure as a template. The bound 6′S sLe x was modified by addition of a sulfate group to the GlcNAc-6 position in ChemBio 3D Ultra 12.0 (Cambridge Soft). To eliminate steric clashes with the inserted sulfate moiety, Lys120 and Gln122 side chains were adjusted with Pymol (Schrö-dinger, LLC). For further refinement, the model was subjected to energy minimization, followed by a 100-ps simulated annealing molecular dynamics in AMBER 12 (54) , with the ff12SB force field and the GLYCAM_06h parameters (55) for the carbohydrate, during which the terminal Neu5Ac (only heavy atoms) was held rigid by imposing a weak positional force constant of 2 kcal/mol·Å 2 , without using any additional restraints.
